Skip to main content
. 2024 Sep 27;15:8360. doi: 10.1038/s41467-024-52128-5

Fig. 6. Kaplan–Meier survival curves of survival probability according to presence of pFGVs in CPGs stratified by MYCN status.

Fig. 6

a Overall survival (OS) for patients without MYCN amplification (TARGET cohort). b OS for patients with MYCN amplification (TARGET cohort). c OS for patients without MYCN amplification (SMC cohort). d OS for patients with MYCN amplification (SMC cohort). Source data are provided as a Source Data file.